Kestra Advisory Services’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-915
Closed -$150K 4139
2025
Q4
$150K Buy
+915
New +$143K ﹤0.01% 3123
2023
Q1
Sell
-1,265
Closed -$214K 2273
2022
Q4
$214K Buy
+1,265
New +$229K ﹤0.01% 1976
2022
Q3
Sell
-1,263
Closed -$205K 2216
2022
Q2
$205K Sell
1,263
-1,432
-53% -$226K ﹤0.01% 1884
2022
Q1
$507K Buy
2,695
+714
+36% +$136K 0.01% 1290
2021
Q4
$525K Buy
1,981
+113
+6% +$30.4K 0.01% 1292
2021
Q3
$540K Buy
+1,868
New +$479K 0.01% 1349

Other funds holding RGEN

Kestra Advisory Services's RGEN Position: Q1 2026 in Review

Kestra Advisory Services sold out of Repligen (RGEN) in Q1 2026, closing a stake of 915 shares — an estimated $150K sold.

Kestra Advisory Services first reported a position in RGEN in Q3 2021 and held it in 6 quarters. The position peaked at $540K in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Kestra Advisory Services reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 915 Repligen shares in Q1 2026, an estimated $150K.
  • Kestra Advisory Services first reported a position in Repligen in Q3 2021 and held it in 6 quarters.
  • Kestra Advisory Services's Repligen position peaked at $540K in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.